Announcements


04.Aug.26Ladas & Parry LLP is pleased to announce that Bharati Bakshani, Lanning Bryer, Ralph...

12.Jun.26Ladas & Parry LLP is pleased to announce that Lanning Bryer, Ralph Cathcart, Sebastian Lovera...

08.Jun.26In a unanimous decision of June 4, 2026 in Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc.,...

23.Apr.26Ladas & Parry was pleased to highlight a series of speaking engagements and industry events...

View all Announcements »


ladas-brochure-download

  • On March 29, 2010, in a controversial decision which, if upheld on appeal, could have far-reaching implications for the biotechnology industry in the United States, the District Court for the Southern District of New York held that isolated genes do...

    Details Share b
  • Creating, registering and protecting trademark rights can be a costly undertaking, whether on behalf of a large corporation’s international portfolio or the single brand of a small...

    Details Share b
  • On January 7, 2010 in its decision in Wyeth and Elan Pharma International Limited v. Kappos, the Court of Appeals for the Federal Circuit held that the United States Patent and Trademark Office (USPTO) had in some cases been miscalculating the...

    Details Share b
  • New York – November 10, 2009 – Ladas & Parry LLP is pleased to announce that Allan S. Pilson, a senior partner and resident in its New York office, was awarded the designation “Member of Honor” of the Inter-American Association of...

    Details Share b
  • In March 2009, we reported that the U.S. Court of Appeals for the Federal Circuit had issued a decision in the case of Tafas v. Doll (formerly, Tafas v. Dudas). Subsequent to that decision, the Federal Circuit granted a rehearing en banc, and...

    Details Share b
  • In its decision in In re Bilski, the Federal Circuit Court of Appeals held that a claim to a process only sets out patent-eligible subject matter if the claim requires use of a particular machine or involved a transformation of something to a...

    Details Share b